7/28/2019 Cardiology Outline
1/6
Cardiology Outline
Cardiology Consist: Clinical Cardiology, Invasive & Non-invasive Cardiology, Cardiac Electrophysiology,
and Interventional Cardiology
General Training days
Tuesday 23 October 2012
General Day 1: Chest Pain & Stable Angina
Tuesday 11 December 2012
General Day 2: Acute coronary syndromes and myocardial infarction
Tuesday 22 January 2013
General Day 3: Cardiovascular response to exercise in health and disease; Cardiac rehabilitation
Monday 11 February 2013
General Day 4: Heart failure Day 2Friday 1 March 2013
General Day 5: Assessment and care of patients before and after cardiac and non-cardiac, surgery
Wednesday 17 April 2013
General Day 6: Heart Disease in Pregnancy
Thursday 20 June 2013
General Day 7: The prevention and management of endocarditis
Friday 5 July 2013
General Day 8: Pre-syncope, syncope and Bradyarrhythmias
Electrophysiology sub specialty training
Monday 3 December 2012
Day 1: Narrow complex tachycardia II
Monday 14th January 2013
Day 2: Cardiac arrhythmias and sudden death: From Bench to Bedside
Thursday 14 February 2013
Day 3: "Pacemaker implantation & programming, managing device-related complications Lead management,
engineering"
Friday 12 April 2013
Day 4: Narrow complex tachycardia III Tracings
Tuesday 14 May 2013
Day 5: Heart Failure and EP
Tuesday 4 June 2013
Day 6: Title to be confirmed
7/28/2019 Cardiology Outline
2/6
Wednesday 3 July 2013
Day 7: Atrial tachycardia
Cardiac imaging sub specialty training
Friday 12 October 2012
Cardiac Imaging Day 1
Wednesday 7 November 2012
Cardiac Imaging Day 2
Friday 8 February 2013
Cardiac Imaging Day 3
Friday 22 February 2013
Cardiac Imaging Day 4
Monday 25 March 2013
Cardiac Imaging Day 5/ BSE
Monday 29 April 29 2013
Cardiac Imaging Day 6
Thursday 27June 27 2013
Cardiac Imaging Day 7
Intervention sub specialty training
Friday 2 November 2012
Coronary artery assessment: Pressure and flow wire, IVUS, OCT
Wednesday 16 January 2013
Non-coronary intervention: Valves, septal ablation, PFO/ASD, carotid and renal interventions Tuesday 12
February 2013
Trial evaluation: design, statistics, interpretation
Wednesday 6 March 2013
PCI for STEMI/ACS: 2b3a, bival, PCI in NSEACS including timing
Friday 19 April 2013
Complications of PCI: Peri-and post-procedure, recognition and management
Thursday 6 June 2013
Complex PCI: CTOs, SVG, LM, bifurcations, calcified lesions
Heart failure sub specialty training
Friday 7 December 2012
7/28/2019 Cardiology Outline
3/6
Heart Failure Day 1
Friday 7 June 2013
Heart Failure Day 1
(also see General day 4 for Heart Failure Day 2)
Adult congenital heart disease
Monday 11 March 2013
ACHD Day1
Friday 27 September 2013
ACHD Day 2
7/28/2019 Cardiology Outline
4/6
Hypertension
Section 3: Genetics of Hypertension
I . Monogenic causes of human hypertension
A. Glucocorticoid remediable aldosteronism
B. Liddles syndrome
C. Apparent mineralocorticoid excess
D. Congenital adrenal hyperplasias
1. Caused by mutations in 11--hydroxylase
2. Caused by mutations in 17--hydroxylase
E. Pseudohypoaldosteronism Type II
F. Hypertension + brachydactyly syndrome
G. Gain of function mutation ofthe mineralocorticoid receptor
I I . Genetics of human primary hypertension
A. Risk of primary hypertension in population
B. Risk of primary hypertens ion in individuals with positive family history
C. Polygenic nature
D. Familial clustering of other cardiovascular risk factors
E. Renal involvement
F. Pharmacogenetic implications
Section 4: Pathophysiologic Mechanisms of Hypertension
I. Hemodynamic Subsets
II. Neural Mechanisms
III. Renal Mechanisms
IV. Vascular Mechanisms
V. Hormonal Mechanisms
A. Renin-Angiotensin-Aldosterone System
7/28/2019 Cardiology Outline
5/6
B. Endothelin
C. Insulin Resistance/Obesity
Section 5: Diagnostic Assessment
I . Accurate and adequate measurement of blood pressure (BP)
A. Office
B. Automatic ambulatory monitoring
C. Home, self- recorded
I I . Additional assessment of prognosis
A. Nocturnal pattern of BP
B. BP on arising
C. BP during exercise
D. Masked hypertension
I I I . White coat hypertension
IV. Initial evaluation
A. Purposes
1. Recognize specific identifiable causes of hypertension
2. Assess target organ damage
3. Determine overall cardiovascular risk status
B. Procedures
1. History
2. Physical examination, including fundoscopic
3. Laboratory testing: routine and additional as indicated
V. Overall cardiovascular risk stratification
Section 6: Metabolic Abnormalities and Hypertension
I . Obesity related hypertension
A. Prevalence of the association
7/28/2019 Cardiology Outline
6/6
B. Pathophysiology
C. Evaluation
D. Management
I I . Dyslipidemia
A. Prevalence of the association
B. Mechanisms
C. Management
I I I . The metabolic syndrome
A. Components of the syndrome
B. Pathophysiology
C. Management
IV. Diabetes mellitus
A. Prevalence of the association with types 1 and 2 diabetes
B. Pathophysiology
C. Evaluation
D. Management
Top Related